Company intelligence / Profile preview
Assure Infusions
- Ownership
- Private
- Development stage
- Commercial
Overview
Assure Infusions has launched a state-of-the-art, fully automated manufacturing facility for sterile IV fluid production. The company aims to address national shortages by providing high-volume, cGMP-compliant supply of critical intravenous solutions to hospitals and healthcare providers. No clinical trial results apply since these are standard-of-care products[3][5][6].
- Therapeutic areas
- OtherNephrology
- Modalities
- Small molecule (for IV fluids such as saline and dextrose)Biologic (for sterile water and Ringer's lactate if classified as such in regulatory context)
- Industry
- Contract Manufacturing Organization
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Assure Infusions.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Assure Infusions.